BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma Research

Sanyou Bio Partners With FatiAbGen to Strengthen Korean Market Presence and Expand Global Biopharma Reach

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") and South Korea's FatiAbGen Co., Ltd. jointly announced the signing of a...

November 28, 2025 | News

HKeyBio Expands Its Autoimmune and Allergy R&D Capabilities With HKEY-AIDMD 3.0 Platform Upgrade

The newly upgraded HKEY-AIDMD 3.0 model library features nearly 300 autoimmune and allergy-related disease models. For multiple major indications, HKeyBi...

November 28, 2025 | News

Exyte Completes Full Integration of Pharmaplan To Strengthen European Leadership in Biopharma Engineering

Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, has completed the integration of Pharmaplan, marking the full tran...

November 26, 2025 | News

Mabwell Doses First Patient in Phase One Two Study of Novel CDH17 Targeting ADC 7MW4911 for Advanced Solid Tumours

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed...

November 26, 2025 | News

BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia

BioMed X, a leading external innovation hub for pharma, announced the launch of a new collaborative research project with AbbVie, hosted at the BioMed...

November 26, 2025 | News

Hoth Therapeutics Joins NVIDIA Connect Program to Advance AI Driven Drug Discovery

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics announced that it h...

November 21, 2025 | News

Rafa Laboratories Secures Major BARDA Contract to Advance Intramuscular Tranexamic Acid for Trauma Care

Rafa Laboratories, a global leader in Chemical, Biological, Radiological, and Nuclear hazards medical countermeasures and Biodefense, announced it ha...

November 20, 2025 | News

Vaxcellbio’s CSO Outlines How DDS Enabled Nanobodies Could Redefine Global Treatment Pathways

Vaxcellbio is betting on the combined power of nanobodies and advanced drug delivery science to push boundaries across ophthalmology and other chronic dise...

November 20, 2025 | Interaction

10x Genomics And ASTRA Consortium Launch Asia Pacific Pan Cancer Spatial Atlas To Advance Precision Oncology

Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region 10x Genomi...

November 19, 2025 | News

Debiopharm Transitions JCA Mauvernay Award Into New IDEAL Japan Programme To Drive Next Generation Oncology Research

After 20 years of the prestigious JCA (Japanese Cancer Association) Mauvernay Award in Japan, Debiopharm is now transitioning its longstanding support ...

November 19, 2025 | News

Terumo BCT Achieves Breakthrough in Automated T Cell Therapy Manufacturing

Terumo Blood and Cell Technologies (Terumo BCT), a global leader in cell and gene therapy technologies, announced an advancement in T cell therapy manufact...

November 19, 2025 | News

Evonik and InVitria Partner to Expand Global Supply of Animal Component-Free Recombinant HSA

Expanded supply of animal component-free human serum albumin for advanced therapies and next-generation biopharmaceutical processes Safer, more consiste...

November 18, 2025 | News

Lundbeck Moves Closer to Asian Launch of Vyepti with New Drug Application Accepted in Japan

Lundbeck's new drug application (NDA) for Vyepti® (eptinezumab) accepted by Japan's Ministry of Health, Labor and Welfare (MHLW), mark...

November 17, 2025 | News

SAS Launches Clinical Acceleration to Modernise Clinical Trial Analytics and Speed Regulatory Submissions

Powered by the data and AI capabilities of SAS Viya, the life sciences solution streamlines drug development to deliver new therapies to patients faster&nb...

November 17, 2025 | News

Stay Connected